Velocity Clinical Research this month expanded its senior management team with the addition of Melissa Holbrook as vice president, operations, a role in which she will be responsible for clinical operations at all of Velocity’s sites.
Holbrook joins Velocity after 13 years at Iqvia, where she was most recently vice president, design and delivery innovation.
Jeff Jensen previously held the position being filled by Holbrook, but is now the senior vice president of corporate development and will focus on the company’s acquisition activity.
According to the company, Velocity is actively pursuing ‘a number’ of acquisition targets and expects to ‘significantly’ increase in size by the end of the year.
In line with this, the company also has hired a new director of human resources and expanded its finance team. Velocity also has partnered with an IT provider that will be responsible for onboarding new sites onto the company’s centralized IT framework.
Said Holbrooke, “I’m thrilled to join Velocity Clinical at an exciting time for the company. As a clinician, I have seen the impact that new and novel therapies can have in improving a patient’s life. Without clinical trials these new therapies would not be possible. I’m very excited to work with these prestigious sites to continue to meet the needs of our patients, our customers, and the communities we serve.”